Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James L. Tyree currently holds 31,566 shares of ABBOTT LABORATORIES (ABT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James L. Tyree has been a net seller of ABT stock. They have purchased $0 and sold $19.5M worth of shares.
James L. Tyree's most recent insider trade was on Jun 16, 2026, when they sold 31,566 shares at $0.00 per share.
James L. Tyree serves as Executive at ABBOTT LABORATORIES (ABT). They have executed 210 insider transactions totaling $19.5M over their tenure at the company.
James L. Tyree holds the position of Executive at ABBOTT LABORATORIES, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
James L. Tyree has shown a selling trading pattern, with $0 in total purchases and $19.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James L. Tyree was on Dec 17, 2021, when they sold $641.3K worth of CCXI shares. This transaction involved 18,066 shares at $35.50 per share.
James L. Tyree currently owns 31,566 shares of ABBOTT LABORATORIES (ABT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James L. Tyree's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James L. Tyree has 210 Form 4 filings on record as an insider at ABBOTT LABORATORIES.
Set alerts for James L. Tyree and 40,000+ other insiders.